<DOC>
	<DOCNO>NCT00720057</DOCNO>
	<brief_summary>To evaluate analgesic efficacy single , oral dose naproxen sodium extended-release tablet , compare placebo postsurgical dental pain .</brief_summary>
	<brief_title>Assessing Analgesic Efficacy Naproxen Sodium Postsurgical Dental Pain .</brief_title>
	<detailed_description />
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Healthy , ambulatory , male female volunteer 16 45 Scheduled undergo surgical removal 1 2 impacted third molar , one must least partial mandibular bony impaction No use analgesic , nonsteroidal antiinflammatory drug ( NSAIDs ) , aspirin , pain reliever ( Over The Counter prescription ) , herbal supplement within 5 day surgery Have moderate severe postoperative pain Categorical Pain Intensity Scale ( score least 2 4 point scale ) score &gt; /= 50 mm 100mm visual analog Pain Severity Rating Scale History hypersensitivity naproxen sodium , aspirin ( ASA ) , NSAIDs , opioid analgesic , similar pharmacological agent component investigational product , include placebo Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic disease , malignancy Relevant concomitant disease asthma ( exercise induce asthma permit ) , chronic sinusitis nasal structural abnormality cause great 50 percent obstruction ( polyposis nasi , mark septal deviation ) interfere conduct study Current past history bleeding disorder ( ) History gastrointestinal bleeding perforation , relate previous NSAID therapy . Active , history recurrent peptic ulcer/hemorrhage ( two distinct episode proven ulceration bleeding )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Dental Pain</keyword>
	<keyword>Analgesia</keyword>
</DOC>